Fused Pyrimidine-Based Drug Discovery - Heterocyclic Drug Discovery - Raj Kumar - Libros - Elsevier - Health Sciences Division - 9780443186165 - 11 de octubre de 2022
En caso de que portada y título no coincidan, el título será el correcto

Fused Pyrimidine-Based Drug Discovery - Heterocyclic Drug Discovery

Precio
$ 267,49
sin IVA

Pedido desde almacén remoto

Entrega prevista 18 de jun. - 7 de jul.
Añadir a tu lista de deseos de iMusic

Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico studies. It covers the chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. N-Heterocyclic scaffolds are found in most known drug candidates, and are of interest to medicinal and organic chemists to design, synthesize and evaluate their biological properties. A variety of fused-pyrimidine molecules have been synthesized and extracted from natural resources, and are found to exhibit various biological activities such as antifolates, anticancer agents, analgesics, antimetabolites, CNS active agents and many more. Some of these scaffolds like purines are also known to have involvement in biological processes and are part of the framework of genetic material. This book focuses on the classification, structural chemistry, and chemical and physical properties along with various approaches for their synthesis. This book is ideal for researchers in organic chemistry both in academic and industrial settings, postgraduates in chemistry and medicinal chemistry.


320 pages

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 11 de octubre de 2022
ISBN13 9780443186165
Editores Elsevier - Health Sciences Division
Páginas 378
Dimensiones 150 × 220 × 10 mm   ·   648 g
Editor Kumar, Raj (Professor of Organic Medicinal Chemistry, Central University of Punjab, Bathinda, India)

Mas por Raj Kumar

Mostrar todo

Mere med samme udgiver